Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024

Core Viewpoint - Agile Therapeutics, Inc. is set to report its fourth quarter and full year 2023 financial results on March 22, 2024, followed by a conference call to discuss these results and provide a business update [1]. Company Overview - Agile Therapeutics is a women's healthcare company focused on addressing unmet health needs of women today [2]. - The company offers contraceptive options that do not require daily intake, with its initial product, Twirla®, being a non-daily prescription contraceptive based on proprietary transdermal patch technology called Skinfusion® [2].